Quick Answer
Incannex Healthcare Inc. reported Research And Development Expense of $10.75 million for the year ending 2025.
- Incannex Healthcare Inc. showed a decrease of -16.6% in Research And Development Expense from 2024 to 2025.
- This data is from Incannex Healthcare Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2022: $1.55 million | Q1 2023: $1.64 million | Q3 2023: $2.61 million | Q4 2023: $2.64 million | Q1 2024: $3.28 million | Q3 2024: $2.90 million | Q4 2024: $1.41 million | Q1 2025: $2.74 million | Q3 2025: $1.12 million | Q4 2025: $2.28 million.
- Over the full 6 years of available data (2020 to 2025), Incannex Healthcare Inc.'s Research And Development Expense has grown by 409.2%.
- Historical annual values: Fiscal year 2025: $10.75 million | Fiscal year 2024: $12.88 million | Fiscal year 2023: $6.31 million | Fiscal year 2022: $5.37 million | Fiscal year 2021: $4.75 million | Fiscal year 2020: $2.11 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: